Poseida Therapeutics Inc (PSTX)
2.65
+0.01
(+0.38%)
USD |
NASDAQ |
Jun 11, 10:06
Poseida Therapeutics Free Cash Flow: -71.71M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -71.71M |
| December 31, 2023 | -95.23M |
| September 30, 2023 | -64.04M |
| June 30, 2023 | -10.96M |
| March 31, 2023 | -17.42M |
| December 31, 2022 | -30.70M |
| September 30, 2022 | -24.58M |
| June 30, 2022 | -125.99M |
| March 31, 2022 | -117.71M |
| Date | Value |
|---|---|
| December 31, 2021 | -105.18M |
| September 30, 2021 | -145.90M |
| June 30, 2021 | -136.80M |
| March 31, 2021 | -143.37M |
| December 31, 2020 | -130.24M |
| September 30, 2020 | -115.72M |
| June 30, 2020 | -104.58M |
| March 31, 2020 | -81.15M |
| December 31, 2019 | -69.67M |
Free Cash Flow Range, Past 5 Years
-145.90M
Minimum
Sep 2021
-10.96M
Maximum
Jun 2023
-88.39M
Average
-99.91M
Median
Free Cash Flow Benchmarks
| Biomea Fusion Inc | -105.08M |
| Cartesian Therapeutics Inc | -58.99M |
| Lantern Pharma Inc | -13.67M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.14M |
| Cash from Investing (Quarterly) | 24.00M |
| Cash from Financing (Quarterly) | -0.043M |
| Free Cash Flow Per Share (Quarterly) | -0.159 |
| Free Cash Flow to Equity (Quarterly) | -15.37M |
| Free Cash Flow Yield | -29.22% |